Researchers at the University of Louisville, Kentucky, have demonstrated that a new radiotracer, 2-¹⁸F-fluorodeoxysorbitol (¹⁸F-FDS), can identify and track bacterial infection in lungs better than current imaging methods and is able to differentiate bacterial infection from inflammation. The study is the featured basic science article in the January issue of The Journal of Nuclear Medicine. {read more here}